Concepts (91)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Extracorporeal Membrane Oxygenation | 14 | 2025 | 621 | 3.630 |
Why?
|
| Peripartum Period | 3 | 2024 | 31 | 1.040 |
Why?
|
| Acute Kidney Injury | 3 | 2021 | 613 | 1.030 |
Why?
|
| Myositis | 1 | 2022 | 51 | 0.790 |
Why?
|
| Churg-Strauss Syndrome | 1 | 2022 | 21 | 0.790 |
Why?
|
| Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis | 1 | 2022 | 21 | 0.790 |
Why?
|
| Granulomatosis with Polyangiitis | 1 | 2022 | 38 | 0.780 |
Why?
|
| Lung Diseases, Interstitial | 1 | 2022 | 147 | 0.720 |
Why?
|
| Pregnant Women | 1 | 2022 | 149 | 0.720 |
Why?
|
| Hospital Mortality | 3 | 2022 | 1009 | 0.720 |
Why?
|
| Cannula | 1 | 2020 | 28 | 0.710 |
Why?
|
| Creatinine | 2 | 2019 | 380 | 0.650 |
Why?
|
| Kidney Function Tests | 1 | 2019 | 126 | 0.640 |
Why?
|
| Survival Analysis | 1 | 2022 | 1472 | 0.600 |
Why?
|
| Registries | 5 | 2023 | 1394 | 0.540 |
Why?
|
| Wounds and Injuries | 2 | 2020 | 365 | 0.380 |
Why?
|
| Retrospective Studies | 9 | 2023 | 16028 | 0.340 |
Why?
|
| Respiratory Insufficiency | 2 | 2023 | 231 | 0.330 |
Why?
|
| Child | 12 | 2024 | 24225 | 0.330 |
Why?
|
| Emergency Service, Hospital | 2 | 2020 | 1070 | 0.280 |
Why?
|
| Trauma Severity Indices | 2 | 2020 | 87 | 0.250 |
Why?
|
| Pica | 1 | 2015 | 2 | 0.250 |
Why?
|
| Oxidants | 1 | 2015 | 25 | 0.240 |
Why?
|
| Jaundice, Neonatal | 1 | 2015 | 11 | 0.240 |
Why?
|
| Hyperbilirubinemia | 1 | 2015 | 41 | 0.240 |
Why?
|
| Humans | 22 | 2025 | 123036 | 0.240 |
Why?
|
| Bilirubin | 1 | 2015 | 121 | 0.230 |
Why?
|
| Delphi Technique | 1 | 2024 | 202 | 0.210 |
Why?
|
| Isoflurane | 1 | 2022 | 45 | 0.210 |
Why?
|
| Antibodies, Antineutrophil Cytoplasmic | 1 | 2022 | 35 | 0.200 |
Why?
|
| Anesthetics | 1 | 2022 | 81 | 0.190 |
Why?
|
| Laboratories, Hospital | 1 | 2021 | 18 | 0.180 |
Why?
|
| Shock | 1 | 2022 | 90 | 0.180 |
Why?
|
| Jugular Veins | 1 | 2020 | 75 | 0.180 |
Why?
|
| Child, Preschool | 5 | 2021 | 13884 | 0.170 |
Why?
|
| Pregnancy | 5 | 2024 | 7161 | 0.170 |
Why?
|
| Patient Admission | 1 | 2021 | 184 | 0.170 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2020 | 211 | 0.170 |
Why?
|
| Adolescent | 6 | 2022 | 19104 | 0.160 |
Why?
|
| Oncogene Proteins, Fusion | 1 | 2020 | 197 | 0.160 |
Why?
|
| Early Diagnosis | 1 | 2019 | 178 | 0.160 |
Why?
|
| Cohort Studies | 3 | 2023 | 4702 | 0.150 |
Why?
|
| Female | 11 | 2024 | 65500 | 0.150 |
Why?
|
| Pregnancy Complications, Infectious | 1 | 2023 | 444 | 0.150 |
Why?
|
| Incidence | 2 | 2021 | 3042 | 0.150 |
Why?
|
| Reference Values | 1 | 2019 | 697 | 0.150 |
Why?
|
| Adult | 6 | 2025 | 29014 | 0.150 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2020 | 530 | 0.140 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2020 | 548 | 0.140 |
Why?
|
| Glioblastoma | 1 | 2020 | 334 | 0.140 |
Why?
|
| Critical Illness | 1 | 2021 | 591 | 0.130 |
Why?
|
| Cross-Sectional Studies | 2 | 2019 | 3367 | 0.130 |
Why?
|
| Sex Factors | 1 | 2019 | 1260 | 0.130 |
Why?
|
| Cardiomyopathies | 1 | 2020 | 478 | 0.120 |
Why?
|
| Asthma | 1 | 2022 | 742 | 0.120 |
Why?
|
| Infant | 4 | 2021 | 12346 | 0.110 |
Why?
|
| Predictive Value of Tests | 1 | 2019 | 2110 | 0.110 |
Why?
|
| Logistic Models | 2 | 2018 | 1789 | 0.110 |
Why?
|
| ROC Curve | 2 | 2020 | 555 | 0.110 |
Why?
|
| Age Factors | 1 | 2019 | 2799 | 0.100 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2021 | 1199 | 0.100 |
Why?
|
| Brain Neoplasms | 1 | 2020 | 1236 | 0.090 |
Why?
|
| Postpartum Period | 2 | 2023 | 213 | 0.090 |
Why?
|
| Biomarkers | 1 | 2019 | 2942 | 0.090 |
Why?
|
| Male | 5 | 2021 | 60069 | 0.090 |
Why?
|
| Infant, Newborn | 4 | 2023 | 8105 | 0.080 |
Why?
|
| Treatment Outcome | 2 | 2021 | 12118 | 0.070 |
Why?
|
| Intensive Care Units, Pediatric | 2 | 2022 | 470 | 0.070 |
Why?
|
| Chi-Square Distribution | 1 | 2018 | 586 | 0.070 |
Why?
|
| United States | 1 | 2022 | 10639 | 0.070 |
Why?
|
| Community-Acquired Infections | 1 | 2018 | 240 | 0.060 |
Why?
|
| Survival Rate | 2 | 2021 | 1997 | 0.060 |
Why?
|
| Early Ambulation | 1 | 2025 | 8 | 0.060 |
Why?
|
| Hemolysis | 1 | 2015 | 105 | 0.060 |
Why?
|
| Odds Ratio | 1 | 2018 | 1240 | 0.060 |
Why?
|
| Pregnancy Complications, Cardiovascular | 1 | 2024 | 104 | 0.050 |
Why?
|
| Hospitals, Pediatric | 1 | 2018 | 779 | 0.050 |
Why?
|
| Length of Stay | 1 | 2018 | 1284 | 0.050 |
Why?
|
| Consensus | 1 | 2024 | 605 | 0.050 |
Why?
|
| Risk Factors | 2 | 2021 | 10006 | 0.050 |
Why?
|
| Systemic Inflammatory Response Syndrome | 1 | 2022 | 171 | 0.040 |
Why?
|
| Hospitals | 1 | 2022 | 396 | 0.040 |
Why?
|
| Shock, Cardiogenic | 1 | 2020 | 187 | 0.040 |
Why?
|
| Practice Guidelines as Topic | 1 | 2025 | 1255 | 0.040 |
Why?
|
| Hemodynamics | 1 | 2022 | 845 | 0.040 |
Why?
|
| Databases, Factual | 1 | 2020 | 1167 | 0.030 |
Why?
|
| Critical Care | 1 | 2021 | 648 | 0.030 |
Why?
|
| Texas | 1 | 2022 | 3560 | 0.030 |
Why?
|
| Follow-Up Studies | 1 | 2022 | 5047 | 0.030 |
Why?
|
| Prognosis | 1 | 2020 | 4513 | 0.020 |
Why?
|
| Young Adult | 1 | 2021 | 8849 | 0.020 |
Why?
|